PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1178

  1. 3,152 Posts.
    lightbulb Created with Sketch. 331
    Hey @DruStar I think my commentsaintain their relevancy on that regard. Regeneus (RGS) may be a better comparator.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.